BACE2 Antibody (Center) Blocking Peptide

BACE2 Antibody (Center) Blocking Peptide

€363.00
In stock
SKU
AC-BP6121a
Catalog Number: AC-BP6121a
Size: 500 µg
Datasheet
Request Information
Background:
Cerebral deposition of amyloid beta peptide is an early and critical feature of Alzheimer's disease and a frequent complication of Down syndrome. Amyloid beta peptide is generated by proteolytic cleavage of amyloid precursor protein by 2 proteases, one of which is the protein encoded by BACE2. This gene localizes to the 'Down critical region' of chromosome 21. The encoded protein, a member of the peptidase A1 protein family, is a type I integral membrane glycoprotein and aspartic protease.

Other Names:
Beta-secretase 2, Aspartic-like protease 56 kDa, Aspartyl protease 1, ASP1, Asp 1, Beta-site amyloid precursor protein cleaving enzyme 2, Beta-site APP cleaving enzyme 2, Down region aspartic protease, DRAP, Memapsin-1, Membrane-associated aspartic protease 1, Theta-secretase, BACE2, AEPLC, ALP56, ASP21

Target/Specificity:
The synthetic peptide sequence used to generate the antibody AP6121a was selected from the Center region of human BACE2 . A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.

Gene Name: BACE2

Gene ID: 25825
Primary Accession: Q9Y5Z0
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
More Information
Is Featured? No
Write Your Own Review
You're reviewing:BACE2 Antibody (Center) Blocking Peptide